G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 08, 2019 at 08:38 am EDT
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 5.433 million compared to TWD 50,000 a year ago. Operating loss was TWD 6.579 million compared to TWD 8.066 million a year ago. Net loss was TWD 6.132 million compared to TWD 6.291 million a year ago. Basic loss per share was TWD 0.11 compared to TWD 0.11 a year ago. For the half year, sales was TWD 7.538 million compared to TWD 116,000 a year ago. Operating loss was TWD 14.913 million compared to TWD 21.362 million a year ago. Net loss was TWD 14.223 million compared to TWD 11.341 million a year ago. Basic loss per share was TWD 0.26 compared to TWD 0.2 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
